A 6-year-old boy with no significant past medical history presents to the emergency department with a 3-day history of fever (39.5°C), productive cough, and right-sided pleuritic chest pain. Vital signs are: HR 118/min, RR 30/min, BP 108/70 mmHg, SpO2 93% on room air. Physical examination reveals diminished breath sounds and crackles in the right lower lobe. Chest radiograph shows right lower lobe consolidation with a small pleural effusion. Sputum culture grows alpha-hemolytic, optochin-sensitive streptococci. The patient has completed the primary pneumococcal vaccination series (PCV13 at 2, 4, 6, and 12-15 months of age). Which of the following best explains how pneumococcal conjugate vaccine (PCV13) prevents invasive pneumococcal infection in vaccinated individuals?
- A)The vaccine contains live attenuated pneumococcal strains that outcompete pathogenic strains in the nasopharynx
- B)The vaccine provides 100% protection against all serotypes of Streptococcus pneumoniae
- C)The vaccine induces opsonizing antibodies against pneumococcal capsular polysaccharides, enhancing complement-mediated bacteriolysis and phagocytosisGABARITO
- D)The vaccine prevents bacterial colonization by neutralizing pneumococcal virulence factors in respiratory secretions
- E)The vaccine cross-reacts with cell wall proteins found on all gram-positive bacteria, providing broad protection
Explicação
PCV13 is a conjugate vaccine that covalently links pneumococcal capsular polysaccharides to a protein carrier (CRM197), which converts the polysaccharide from a T-independent to a T-dependent antigen. This generates opsonizing IgG antibodies that coat the bact... Ver explicação completa e trilha adaptativa →